VistaGen Therapeutics Inc Capital Reinvestment Ratio

Latest as of September 2020: 0.10x

VistaGen Therapeutics Inc capital reinvestment ratio. VistaGen Therapeutics Inc (VTGN) has a Capital Reinvestment Ratio of 0.10x as of September 2020, meaning it reinvests 0% of its operating cash flow ($1.00 Million) in capital expenditures ($98.80K). Check how aggressively does VistaGen Therapeutics Inc reinvest cash to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.10x

Capex / Operating Cash Flow

Operating Cash Flow

$1.00 Million

USD

Capital Expenditures

$98.80K

USD

Data as of

Sep 2020

Most recent filing

VistaGen Therapeutics Inc Capital Reinvestment Ratio by Year (None–None)

VistaGen Therapeutics Inc capital reinvestment ratio by year from None to None. For the full cash flow conversion analysis, see VistaGen Therapeutics Inc (VTGN) cash conversion ratio.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow